Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR2 | O95665 | 6/20 | 0.55 |
| ▸ | REN | P00797 | 2/20 | 0.52 |
| ▸ | NTSR1 | P30989 | 5/20 | 0.50 |
| ▸ | NMUR2 | Q9GZQ4 | 5/20 | 0.50 |
| ▸ | SORT1 | Q99523 | 4/20 | 0.50 |
| ▸ | NMUR1 | Q9HB89 | 4/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29673326 | 0.92 | NTSR2 (0.63) | NTSR2RENNTSR1SORT1SLC6A2 | |
| SCHEMBL30446614 | 0.89 | NTSR2 (0.56) | NTSR2RENNTSR1NMUR2SORT1 | |
| Trifluoroacetic Acid SCHEMBL30641541 | 0.89 | NTSR2 (0.60) | NTSR2RENNTSR1SORT1SLC6A2 | |
| SCHEMBL30233455 | 0.85 | STAT3 (0.52) | NTSR2RENNTSR1NMUR2NMUR1 | |
| SCHEMBL30248935 | 0.84 | REN (0.52) | NTSR2RENNTSR1NMUR2SORT1 | |
| SCHEMBL30446679 | 0.84 | NTSR2 (0.55) | NTSR2RENNTSR1NMUR2SORT1 | |
| SCHEMBL30368311 | 0.84 | REN (0.58) | REN | |
| SCHEMBL31362679 | 0.84 | SLC6A2 (0.56) | RENSLC6A2 | |
| SCHEMBL13599743 | 0.83 | KDM1A (0.55) | NTSR2RENNTSR1NMUR2SORT1 | |
| SCHEMBL1661256 | 0.82 | NMUR2 (0.54) | RENNMUR2NMUR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115298194-B | VIPR2 antagonistic peptide | 一丸自然美健有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20250186540-A1 | VIPR2 ANTAGONIST PEPTIDE FOR SUPPRESSING CANCER METASTASIS | ICHIMARU PHARCOS CO., LTD. (JP) | 2025-06-12 | — | — | US | disclosed |
| CN-118742316-A | VIPR2 antagonistic peptide for inhibiting cancer metastasis | 一丸自然美健有限公司 | 2024-10-01 | — | — | CN | disclosed |